Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells / Elaskalani, O; Domenichini, A; Abdol Razak, Nb; E Dye, D; Falasca, M; Metharom, P. - In: CANCERS. - ISSN 2072-6694. - (2020). [10.3390/cancers12010250]

Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells

Falasca M;
2020-01-01

2020
Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells / Elaskalani, O; Domenichini, A; Abdol Razak, Nb; E Dye, D; Falasca, M; Metharom, P. - In: CANCERS. - ISSN 2072-6694. - (2020). [10.3390/cancers12010250]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2959489
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 28
social impact